Table 2.
Antifungal susceptibility of isolates in minimum inhibitory concentration (MIC (μg/mL))
| Case no | FLU | VRC | FC | AMB | CAS | MFG | Antifungal medication provided for the patient |
|---|---|---|---|---|---|---|---|
| 1 | SDD (4) | R (2) | R (≥64) | R (2) | S (0.25) | S (0.12) | The patient was discharged against medical advice; hence, no antifungal therapy was initiated on the patient. |
| 2 | R (8) | R (1) | R (≥64) | R (8) | S (0.25) | S (≤0.06) | No antifungal therapy was recommended as there was no evidence of infection. |
| 3 | R (32) | R (1) | R (≥64) | R (8) | S (0.25) | S (≤0.06) | No antifungal therapy was recommended as there was no evidence of infection. |
| 4 | R (8) | R (2) | R (≥64) | R (2) | S (0.25) | S (0.12) | The patient was discharged against medical advice; hence, no antifungal therapy was initiated on the patient. |
| 5 | R (16) | R (2) | R (≥64) | R (8) | S (0.25) | S (0.12) | No antifungal therapy was recommended as there was no evidence of infection. |
| 6 | R (32) | R (2) | R (≥64) | S (0.5) | S (0.25) | S (0.12) | The patient was started on injection of Caspofungin 50 mg (intravenous) OD with a loading dose of 70 mg IV, in view of candidemia. IV Caspofungin was provided for a total of 18 days. |
| 7 | R (32) | R (2) | R (≥64) | R (8) | S (0.25) | S (0.12) | The patient was started on injection of Caspofungin 50 mg (intravenous) OD with a loading dose of 70 mg IV, in view of candidemia. IV Caspofungin was given for a total of 11 days. |
AMB: Amphotericin; CAS: Caspofungin; FC: Flucytosine; FLU: Fluconazole; MFG: Micafungin; MIC: Minimum inhibitory concentration; SDD: Susceptible-dose dependent; VRC: Voriconazole; OD: Once a day